More than 1,300 Florida A&M University students turned their tassels during the spring commencement at the Alfred Lawson Jr.

Eli Lilly and Company (NYSE: LLY) today announced its financial results for the first-quarter of 2025.

Lilly, which has its headquarters in Indianapolis, first announced that it would be seeking approval from Limerick City and ...

LLY's post-market drop offers investment potential with robust R&D, capex strategies, and strong cash flow, positioning it ...

Eli Lilly’s expanding US production and advancing pipeline offset near-term headwinds and support bullish conviction. Read ...

CNBC's Jim Cramer on Friday highlighted the most market-moving events of next week, including earnings reports from Disney, Palantir and Uber. He also remarked on the turbulent nature of the market as ...

In 2024, the European Medicines Agency (EMA) approved lecanemab for the treatment of early Alzheimer's disease in patients without contraindications or risk factors for side-effects. This approval ...

Adding to the pressure is that CVS Health has retained coverage of Zepbound's arch rival Wegovy (semaglutide), sold by Novo ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Investing.com -- Novo Nordisk (NYSE: NVO) shares climbed 5.4% Friday after the U.S. Food and Drug Administration accepted the ...

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...